Gufic Biosciences [GUFICBIO] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Gufic Biosciences

NSE

Sun Pharma Advanced

NSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Gufic Biosciences wins in 11 metrics, Sun Pharma Advanced wins in 6 metrics, with 0 ties. Gufic Biosciences appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Gufic Biosciences	Sun Pharma Advanced	Better
P/E Ratio (TTM)	51.29	-13.34	Sun Pharma Advanced
Price-to-Book Ratio	5.95	-21.04	Sun Pharma Advanced
Debt-to-Equity Ratio	55.93	-1.24	Sun Pharma Advanced
PEG Ratio	N/A	0.29	N/A
EV/EBITDA	29.56	-16.99	Sun Pharma Advanced
Profit Margin (TTM)	7.36%	-53.22%	Gufic Biosciences
Operating Margin (TTM)	11.44%	-568.05%	Gufic Biosciences
EBITDA Margin (TTM)	11.44%	N/A	N/A
Return on Equity	11.59%	157.88%	Sun Pharma Advanced
Return on Assets (TTM)	5.96%	-102.08%	Gufic Biosciences
Free Cash Flow (TTM)	$470.43M	$-3.71B	Gufic Biosciences
Dividend Yield	0.03%	N/A	N/A
1-Year Return	3.12%	-34.25%	Gufic Biosciences
Price-to-Sales Ratio (TTM)	4.25	70.46	Gufic Biosciences
Enterprise Value	$38.91B	$48.18B	Sun Pharma Advanced
EV/Revenue Ratio	4.63	74.59	Gufic Biosciences
Gross Profit Margin (TTM)	56.26%	-10.68%	Gufic Biosciences
Revenue per Share (TTM)	$84	$2	Gufic Biosciences
Earnings per Share (Diluted)	$6.95	$-9.19	Gufic Biosciences
Beta (Stock Volatility)	0.14	0.31	Gufic Biosciences

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Gufic Biosciences vs Sun Pharma Advanced Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Gufic Biosciences	2.06%	-1.16%	0.56%	-5.54%	-11.25%	-21.91%
Sun Pharma Advanced	2.40%	-3.92%	-13.01%	-6.93%	-0.76%	-30.12%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Gufic Biosciences	3.12%	77.94%	287.71%	968.97%	5,029.50%	1,066.94%
Sun Pharma Advanced	-34.25%	-41.92%	-22.97%	-66.04%	46.46%	-51.75%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Gufic Biosciences (GUFICBIO): View Full Stock Overview

Sun Pharma Advanced (SPARC): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Gufic Biosciences vs Sun Pharma Advanced

Metric	GUFICBIO	SPARC
Market Information
Market Cap i	₹35.75B	₹45.51B
Market Cap Category	Small cap	Small cap
10 Day Avg. Volume i	43,002	286,063
90 Day Avg. Volume i	63,414	352,245
Last Close	₹363.85	₹143.61
52 Week Range	₹298.80 - ₹504.25	₹109.30 - ₹241.00
% from 52W High	-27.84%	-40.41%
All-Time High	₹26,990.00 (Oct 30, 2023)	₹875.00 (Apr 24, 2006)
% from All-Time High	-98.65%	-83.59%
Growth Metrics
Quarterly Revenue Growth	0.10%	-0.43%
Quarterly Earnings Growth	-0.37%	-0.43%
Financial Health
Profit Margin (TTM) i	0.07%	-0.53%
Operating Margin (TTM) i	0.11%	-5.68%
Return on Equity (TTM) i	0.12%	1.58%
Debt to Equity (MRQ) i	55.93	-1.24
Cash & Liquidity
Book Value per Share (MRQ)	₹59.96	₹-6.69
Cash per Share (MRQ)	₹2.89	₹0.06
Operating Cash Flow (TTM) i	₹833.57M	₹-3,484,287,000
Levered Free Cash Flow (TTM) i	₹696.50M	₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i	0.03%	N/A
Last 12-Month Dividend i	₹0.10	N/A

Valuation & Enterprise Metrics Analysis: Gufic Biosciences vs Sun Pharma Advanced

Metric	GUFICBIO	SPARC
Price Ratios
P/E Ratio (TTM) i	51.29	-13.34
Forward P/E i	N/A	2.53
PEG Ratio i	N/A	0.29
Price to Sales (TTM) i	4.25	70.46
Price to Book (MRQ) i	5.95	-21.04
Market Capitalization
Market Capitalization i	₹35.75B	₹45.51B
Enterprise Value i	₹38.91B	₹48.18B
Enterprise Value Metrics
Enterprise to Revenue i	4.63	74.59
Enterprise to EBITDA i	29.56	-16.99
Risk & Other Metrics
Beta i	0.14	0.31
Book Value per Share (MRQ) i	₹59.96	₹-6.69

Financial Statements Comparison: Gufic Biosciences vs Sun Pharma Advanced

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	GUFICBIO	SPARC
Revenue/Sales i	₹2.05B	₹96.40M
Cost of Goods Sold i	₹896.68M	₹106.70M
Gross Profit i	₹1.15B	₹-10.30M
Research & Development i	N/A	N/A
Operating Income (EBIT) i	₹185.30M	₹-547.60M
EBITDA i	₹267.68M	₹-429.40M
Pre-Tax Income i	₹105.25M	₹-518.10M
Income Tax i	₹28.05M	₹600,000
Net Income (Profit) i	₹77.20M	₹-518.70M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	GUFICBIO	SPARC
Cash & Equivalents i	₹157.23M	₹19.64M
Total Current Assets i	₹6.25B	₹261.97M
Total Current Liabilities i	₹3.88B	₹3.74B
Long-Term Debt i	₹1.50B	₹1.07B
Total Shareholders Equity i	₹6.01B	₹-2.17B
Retained Earnings i	N/A	₹-23.22B
Property, Plant & Equipment i	₹5.00B	₹178.02M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	GUFICBIO	SPARC
Operating Cash Flow i	N/A	N/A
Capital Expenditures i	N/A	N/A
Free Cash Flow i	N/A	N/A
Debt Repayment i	N/A	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	GUFICBIO	SPARC
Shares Short i	N/A	N/A
Short Ratio i	N/A	N/A
Short % of Float i	N/A	N/A
Average Daily Volume (10 Day) i	43,002	286,063
Average Daily Volume (90 Day) i	63,414	352,245
Shares Outstanding i	100.28M	324.52M
Float Shares i	25.86M	91.74M
% Held by Insiders i	0.78%	0.73%
% Held by Institutions i	0.03%	0.02%

Dividend Analysis & Yield Comparison: Gufic Biosciences vs Sun Pharma Advanced

Metric	GUFICBIO	SPARC
Last 12-Month Dividend i	₹0.10	N/A
Last 12-Month Dividend Yield i	0.03%	N/A
3-Year Avg Annual Dividend i	₹0.13	N/A
3-Year Avg Dividend Yield i	0.04%	N/A
3-Year Total Dividends i	₹0.40	N/A
Ex-Dividend Date	Sep 17, 2024	N/A

Gufic Biosciences [GUFICBIO] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison